JPRN-UMIN000008029已完成2 期
A feasibility study of capecitabine and oxaliplatin (XELOX) for patients with stage II/III colon cancer. - ACTOR study
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Severe peripheral sensory neuropathy 2. History of the serious hypersensitivity for drugs. 3. Active infection. 4. Complications (Evidence of interstinal lung disease, or pulmonary fibrosis, paralytic or mechanical bowel obstruction, uncontrolled hypertension, uncontrolled diabetes mellitus, cirrhosis, active cardiovascular disease, or past or current history (within 3 months) of myocardial infarction. 5. Multiple primary cancer within 5years. 6. Uncontrolled diarrhea. 7. Clinically significant mental or psychological disease. 8. Pregnancy, lactation period. 9. Other conditions not suitable for this study
研究者
相似试验
尚未招募
不适用
A feasibility study of capecitabine plus oxaliplatin (CapeOX) and S-1 plus oxaliplatin (SOX) for unresectable advanced or reccurent gastric cancerunresectable advanced or reccurent gastric cancerJPRN-UMIN000015258Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital40
已完成
不适用
Phase II study of Capecitabine + oxaliplatin(CapeOx) for elderly patients with untreated metastatic gastric cancer <TCOG GI-1601>ntreated metastatic gastric cancerJPRN-UMIN000022450The Tokyo Cooperative Oncology Group110
终止
2 期
Title XELOX FOR SALIVARY GLAND CANCERSHead and Neck CancerNCT00101075Dana-Farber Cancer Institute9
已完成
不适用
A phase II study of capecitabin plus oxaliplatin therapy (XELOX) for inoperable/advanced gastric cancer resistant/intolerable to fluoro-pyrimidine, CDDP, Taxane or CPT-11 (OGSG1403)unresectable/advanced gastric cancerJPRN-UMIN000016256Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)12
进行中（未招募）
不适用
Phase II clinical trial of capecitabine and oxaliplatin plus bevacizumab as neoadjuvant treatment for patients with previously untreated unresectable liver-only metastases from colorectal cancer - BOXERMetastatic colorectal adenocarcinoma with metastases involving the liver onlyMedDRA version: 8.1Level: PTClassification code 10010035Term: Colorectal cancer stage IVEUCTR2005-004505-29-GBRoyal Marsden NHS Trust46